Listeriosis is a foodborne disease of significant public health concern. Exposure to Listeria in food may be relatively common. Disease typically occurs as a result of the failure of cell-mediated immunity to control proliferation of Listeria in the liver, which leads to bacteremia and invasion of other organs [1] . Even though its incidence is low, ranging from 0.1 to 1 cases per 100 000 population, listeriosis is responsible for 19% of known causes of foodborne disease-related death in the United States and 17% in France [2, 3] . More than 70% of cases of listeriosis occur in persons with recognized underlying diseases such as liver disease, cancer, and diabetes. Estimates of incidence in these groups have not been published, although the relative degree of risk posed by different underlying conditions provides crucial information to establish and prioritize prevention programs that target the highest-risk populations. In addition, incidence estimates in different subgroups of the population are essential for building and refining risk analysis models to guide food regulatory activities. The study that we report here estimated the risk of listeriosis by underlying condition among residents of France to identify groups for which prevention messages should be targeted in priority.
METHODS

Surveillance of Listeriosis in France
Since 1999, surveillance of human listeriosis in France has been based on mandatory notification of cases. Confirmed cases must be reported by physicians to the regional health agencies using a standardized form that documents demographic and clinical information, including disease presentation, underlying conditions (diseases, immunosuppressive treatment, pregnancy), and disease outcome. Notification forms are then sent to the Institut de Veille Sanitaire (InVS), the national public health surveillance institute for France, to analyze case characteristics and temporal trends [4] . For this study, we reviewed cases of listeriosis reported to InVS from 2001 to 2008. Numbers of cases and deaths were tabulated by age and underlying condition.
Case Definitions
A case was defined by isolation of Listeria monocytogenes (LM) from a normally sterile site in a patient with a clinically compatible illness. A case was considered pregnancy-associated if it involved a pregnant woman, a miscarriage, a stillbirth, or a newborn ,1 month old. When LM was isolated from both the pregnant women and her newborn, the event was counted as a single case. Cases were assigned to only 1 underlying condition. If a patient had .1 underlying disease, the case was grouped according to the condition considered to be the most immunosuppressive. Cases not associated with pregnancy were defined as a central nervous system (CNS) case (LM isolated from cerebrospinal fluid [CSF] or blood culture with clinical symptoms of CNS involvement), a bacteremic case (LM isolated from blood culture with no clinical signs of CNS involvement), or a focal case (LM isolated in a specimen other than CSF or blood culture; eg, ascites fluid).
Underlying Conditions
Prevalence estimates for underlying conditions were derived from different data sources (Table 1) .
For cancer, total prevalence refers to all persons diagnosed in the past with cancer including those considered as cured. In France, only 5-year prevalence data are available. This includes persons diagnosed in the 5 years before the reference date. We estimated 5-year prevalence of cancers for 2005 from 5-year prevalence trend data published by Colonna et al [5] . Scandinavian countries that have a long tradition of cancer registration with national coverage (NORDCAN database) are able to provide 5-year and total prevalence estimates annually [6] . For our study, the total prevalence of cancer was estimated by combining published data on 5-year prevalence in France and the ratio of total prevalence to 5-year prevalence issued from NORDCAN. Data from the European study EUROPREVAL have shown that the ratios of total prevalence to 5-year prevalence observed in Regional population-based survey [14] Inflammatory diseases
Prevalence of ulcerative colitis and Crohn's French registry of inflammatory diseases (EPIMAD) [15] Prevalence of rheumatoid arthritis Study on a random sample of French population [16] France and in Scandinavian countries are similar [7] . Prevalence could be estimated by this method for all cancers including leukemia (all types combined) but not for chronic lymphocytic leukemia (CLL), which is not present in NORDCAN. We estimated the prevalence of CLL by applying the proportion of CLL/leukemia (44.6%) given by the Normandy French register of hematologic cancers to total leukemia prevalence estimated through NORDCAN [8] .
Diabetes prevalence was estimated through a cross-sectional survey and from 2 studies made of the French National Health Insurance database giving the ratio of type 1 diabetes to type 2 diabetes and age distribution [9] [10] [11] .
Data on AIDS, transplantation, dialysis, giant cell arteritis, ulcerative colitis, and Crohn's disease were obtained from databases managed by agencies or registries in charge of these diseases or published reports [12] [13] [14] [15] [16] [17] .
For estimating the total number of persons with underlying conditions, we applied age group-specific prevalence estimates to population data obtained from the French National Institute of Statistics [8] for 3 age groups: ,65 years, 65-74 years, and .74 years. Numbers of persons with no underlying conditions were obtained for each age group by subtracting the combined prevalence estimates from the total French population of this age.
Data Analysis
Risk Ranking
Several measures of the impact of specific underlying conditions on the occurrence of listeriosis were calculated. These included the following: mean incidence rates per 100 000 persons with the underlying condition, risk ratios that compared these incidence rates to the incidence rate of a reference population of persons ,65 years of age with no underlying conditions, number of deaths by underlying condition reported among cases of listeriosis, and case-fatality ratios of listeriosis by group of persons with underlying condition (Table 2 ). For pregnancy-associated cases, only fetal/neonatal deaths were reported; no deaths occurred among pregnant women. Underlying conditions were ranked according to the degree to which they increased the risk of listeriosis ( Figure 1 ). Mortality Univariate and multivariate analyses by multiple logistic regression were performed using STATA software, version 8.2 to identify factors (age, sex, clinical presentation, immunosuppressive treatment, most frequent underlying diseases [. 16 cases]) independently associated with death in the population of nonpregnancy-associated listeriosis cases.
RESULTS
From 2001 to 2008
, 1959 cases of listeriosis were reported among residents of France (annual mean incidence, 0.39 per 100 000 residents). Seventeen percent (n 5 347) were pregnancyassociated cases, an annual rate of 5.6 cases per 100 000 pregnancies. Among the 1612 residents with nonpregnancyassociated listeriosis, 57% were male, 38% were aged $75 years, 25% were aged 65-74 years, 37% were aged ,65 years, 65% had an underlying disease, and 41% had an immunosuppressive treatment. A majority of nonpregnancy-associated cases (63%) were bacteremic, 32% were CNS cases, and 5% were focal cases.
Among persons with no underlying disease, incidence rates increased with age from 0.05 cases per 100 000 persons ,65 years to 0.98 cases per 100 000 persons $75 years (Table 2) .
Incidence rates of listeriosis varied widely by underlying disease ranging from 0.19 cases per 100 000 cases of kidney cancer to 55 cases per 100 000 cases of CLL. Persons with hematological malignancies had the highest incidence (10-50 per 100 000) with the exception of Hodgkin's disease, for which the incidence rate was 1 case per 100 000 persons.
Incidence was the highest (.5 per 100 000) for persons with CLL; liver cancer; myeoloproliferative disorder; giant cell arteritis; dialysis; multiple myeloma; esophageal, stomach, pancreas, lung, and brain cancer; cirrhosis; acute leukemia; organ transplantation; and pregnancy ( Figure 1 ). Compared with persons aged ,65 years with no underlying conditions, these groups had a .100-fold increased risk of listeriosis Incidence was low (,0.5 per 100 000) for persons with type 2 diabetes, kidney cancer, valvular disease, and aged 65-74 years with no underlying disease. Incidence in the elderly group (aged $75 years) with no underlying disease was moderate (1 case per 100 000 persons).
For the majority of underlying conditions, the case fatality rate of listeriosis ranged from 20% to 40%, with the highest for listeriosis cases with lung and pancreatic cancer. The case fatality rate was lowest for organ recipients (6%) and for persons aged ,75 years with no underlying disease (7%).
Listeriosis, age $80 years, and all underlying conditions except diabetes and valvulopathy were associated with an increased risk of death, both in univariate and multivariate analysis. Bacteremia was associated with death in univariate analysis, but when adjusting on other factors, this association was no longer significant, whereas CNS involvement was identified as a risk factor independently associated with death. Immunosuppressive treatments and sex were not associated with death (Table 3) .
The groups of persons whose underlying conditions were associated with the highest incidence of listeriosis (.5 cases per 100 000 persons) accounted for 43% of cases and 55% of deaths, but only 1% of the total population, whereas groups with low incidence accounted for 21% of cases, 21% deaths, and 16% of the whole population ( Figure 2 ). The population considered not at risk (no underlying condition and age ,65 years) accounted for 10% of cases, 2% of deaths, and 75% of the whole population. 
DISCUSSION
There are 2 primary strategies for reducing exposure to LM and its impact on health: reducing contamination of food products and providing dietary recommendations to avoid high-risk food. Contamination of the food supply can be reduced by improving food hygiene from farm to fork. However, because LM is ubiquitous and can persist in food preparation environments, this approach has inherent limits. Surveys monitored in the United States and in France have indicated that .1% of readyto-eat foods are contaminated by LM, with the highest rate in smoked seafood and meat products [18, 19] . The second approach is to target high-risk groups with health education to reduce LM proliferation in foods stored at home before consumption and to avoid eating high-risk foods. To increase their efficiency, health education efforts should be targeted at persons who are at greatest risk of acquiring this infection and account for a substantial proportion of cases and deaths. Our data 
gathered on 1959 cases of listeriosis between 2001 and 2008 in
France offered a unique opportunity to determine those at highest risk of listeriosis and the number of deaths by ''at-risk group'' to identify relevant population subgroups to target. Previous studies have assessed the proportion of cases of listeriosis by underlying condition but without reference to the size of the population affected by that underlying condition. Such studies do not provide absolute estimates of risk and do not allow comparisons of risk levels by underlying condition. To identify those with underlying conditions in whom incidence was the highest, we had to obtain appropriate population denominators for each underlying condition to calculate specific incidence rates. Because prevalence data for chronic diseases are generally less available than incidence data, we had to estimate prevalence rates by combining different data sources. Therefore, population estimates that we obtained for each underlying condition have to be considered as proxies of their true size. The total population of persons with underlying diseases was obtained by adding all groups with underlying diseases, not taking into account that some persons may have multiple conditions. For instance, persons with cancer and diabetes would be counted twice. Thus, the size of the population with any underlying conditions is overestimated, whereas the number of those without underlying disease (obtained by subtracting those with any underlying disease from the total population) is underestimated. Therefore, our incidence estimates for the population with no underlying condition are likely to be overestimated, which would tend to bias risk ratios for underlying diseases to lower values. However, because the estimated population size with no underlying risk accounts for at least 75% of the whole population, the biasing effect is likely to be marginal.
Also, some persons with listeriosis have multiple conditions. Among the conditions that we assessed, the 2 that are the most concurrent with others are diabetes and cirrhosis. The choice of 1 condition (cirrhosis for a patient with diabetes and cirrhosis) has an impact on the estimate of incidence. If we had considered all cases of listeriosis with diabetes mellitus without taking out those who also had cirrhosis, the incidence among diabetes would have changed from 1.6 to 2.9 cases per 100 000, an increase of almost 100%. However, it would not have changed the risk ranking for diabetes mellitus based on risk ratios. With an incidence of 5.6 cases per 100 000 pregnancies, pregnant women are among the highest-risk groups. This incidence may be underestimated due to cases occurring in the first term of pregnancy that are undiagnosed.
Our incidence estimates are influenced by the level of reporting of listeriosis. However, the sensitivity of surveillance of listeriosis, estimated at .90% through a capture-recapture analysis between the mandatory notification surveillance system and an independent laboratory surveillance system for LM, is quite high in France [4] .
Only 2 studies have attempted to quantify risk of listeriosis by predisposing condition. In the study made in Denmark in 1989-1990 with a similar methodology on 59 patients with listeriosis, hematological malignancies were the diseases with the highest risk levels [20] . Because this study was conducted years before the availability of antiviral therapy for human immunodeficiency virus infection, patients with AIDS also had a high risk level. In our study, listeriosis incidence was low in persons with AIDS. A more recent study was conducted in the United Kingdom in a similar period (1999-2009) on 1239 cases [21] . The methodology was quite different. The denominator was not the population with the disease but the number of hospital episodes aggregated by International Classification of Diseases, Tenth Revision code. As in our study, they identified hematological malignancies and liver diseases as having the highest risks. Concurrently, they identified people with diabetes mellitus as part of the population with high risk. Persons that are hospitalized for diabetes mellitus often have concomitant pathologies that may act as a confounding factor. In our study, patients with diabetes mellitus have an incidence of listeriosis much lower than in patients with hematological malignancies and liver diseases and are not part of the high-risk group. We think that using a population denominator provides a more accurate identification of population groups at which prevention measures should be targeted. Mortality is also a criterion to take into account to select target groups for prevention. Mortality from listeriosis was similar in patients with diabetes as for patients with no underlying diseases. In contrast, mortality risk from listeriosis in patients with hematological malignancies and liver disease was increased by .5-fold compared with patients with no underlying disease. Due to the large number of cases included in our study, we identified more risk factors for lethal outcome than in previous studies conducted in Denmark (n 5 299) and in California (n 5 285) [22, 23] . Among the 18 underlying diseases included in our analysis, all except diabetes and valvular diseases were significantly associated with an increased mortality independent of age, treatment, clinical presentation, and sex. Age $80 years and CNS involvement were also independently associated with an increase in mortality. As noted in a previous study, treatment-induced immunosuppression was not associated with increased mortality [24] .
Targeting high-risk groups to reduce the risk of listeriosis needs to take into account risk estimates and number of listeriosis cases associated with the identified risk groups. Proposed measures have to be acceptable for those risk groups. Because targeted measures include avoiding specific foods, one has to balance the number of cases that can be prevented with the number of persons who will have to modify their food habits and potentially their nutritional status and the quality of life associated with their food preferences. In addition, targeting high-risk groups needs to be feasible, for instance, through opportunities for health education (eg, antenatal visits).
We have shown that patients with CLL were the most vulnerable to listeriosis, with an incidence .1000 times greater than the population with no risk factors. Mortality due to listeriosis among patients with CLL was also much higher than for other underlying conditions. Special attention is therefore warranted for these patients, in particular, the admonition to not eat foods that are at risk of contamination with LM. Because this condition is very specific, and these patients are cared for by specialized physicians, targeting information to these patients should be feasible. We also showed that 14 underlying conditions were associated with a high (.100-fold) increased risk of listeriosis and accounted for 43% of cases and 55% of deaths. Targeting food recommendations to the patients with these 14 underlying conditions will probably be more effective, feasible, and acceptable than trying to broadly change behavior for large population groups, or for all elderly patients.
In France, pregnant women are the only group for whom official recommendations (food hygiene and avoidance of at-risk food) are actively promoted [25] . Because pregnancy is a condition of limited duration, recommendations to avoid high-risk foods are usually acceptable, and opportunities exist to channel the messages during prenatal visits.
We showed that the incidence of listeriosis is extremely low in the population with no underlying disease, even in the elderly population. Food avoidance recommendations for groups at risk (such as the elderly) would be of less benefit in terms of cases avoided, would need to be lifelong, and may have nutritional side effects (such as weight loss) in this population.
CONCLUSIONS
To be effective and acceptable to physicians and patients, LM prevention strategies should be based on evidence of increased risk of illness and death. Our study including 1959 cases substantially builds the evidence base for public health recommendations. During the 1990s, the incidence of listeriosis was reduced after the implementation of Listeria control measures during food production. Although control of food production is the major intervention to reduce contamination and avoid infection throughout the population, we know that it is impossible to eradicate LM from all foods and that there will remain food contaminated with low levels of LM at the retail level. To avoid LM growth in an accidently contaminated product, proper food storage and food handling practices should be promoted primarily to those most at risk of listeriosis as identified in our study. For pregnant women and for those persons at greatest risk of listeriosis (such as patients with CLL), even more stringent dietary guidance to avoid specific at-risk foods of LM contamination should be considered.
